myocarditis Archives - Page 3 of 3 - Health Freedom Defense Fund

Incidence of myocarditis and pericarditis considered as separate clinical events over the years and post-SARS-CoV2 vaccination in adults and children

Moderna recipients in Italy were 6 times more likely to develope myocarditis during the high risk period (28 days after shot)

Epidemiology of Myocarditis and Pericarditis Following mRNA Vaccination by Vaccine Product, Schedule, and Interdose Interval Among Adolescents and Adults in Ontario, Canada

Notes higher rates of heart damage in young males, 3 days post vaccination. Urges caution and to consider timing to reduce such damage.

Persistent cardiac magnetic resonance imaging findings in a chohort of adolescents with post-coronavirus disease 2019 and mRNA vaccine myopericarditis

Heart abnormalities in teens post-vaccination persisted for months.

Increased cardiovascular events among under-40 population in Israel during vaccine rollout and third COVID-19 wave.

For adults over 40, emergency calls for cardiac arrest and ACS during vaccination period, but no difference from 2019 to 2020. for younger people, calls increased by 25% during vaccine rollout. inference is that covid Vaccination signficantly increases the risk of severe heart damage

Top 10 drugs most frequently associated with adverse events of myocarditis and pericarditis

This study highlights the unique danger from mRNA shots, of events like myocarditis and pericarditis, compared to other pharmaceutical products.

COVID-19 vaccines and adverse events of special interest: A multinational Global Vaccine Data Network (GVDN) cohort study of 99 million vaccinated individuals

Expansive study of over 99 million people in Vaccine, which analyzes the outcomes for those who took mRNA and viral vector injections, and confirms well-known side effects of note, and identifies new adverse events for further investigation.